🔗 #StemCellEvidence link to:

Single-cell analysis of adaptive NK and CMV-specific T-cell dynamics after allogeneic HSCT
by Häkkinen et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🟣From the #StemCellEvidence alert:

📑Single-cell analysis of adaptive NK and CMV-specific T-cell dynamics after allogeneic HSCT
by Häkkinen et al.

🔗Link in the comments

🔗 #StemCellEvidence link to:
Donor HLA-E*01:06 Confers Protection from Relapse and Improved Survival after T-Cell Depleted Matched Unrelated Donor Hematopoietic Cell Transplantation by Lucas et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

➡️ New from the #StemCellEvidence alert:

📑 Donor HLA-E*01:06 Confers Protection from Relapse and Improved Survival after T-Cell Depleted Matched Unrelated Donor Hematopoietic Cell Transplantation by Lucas et al.

🔗 Link in the comments
#MedSky

🔗 #StemCellEvidence link to:
Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study
by Li et al.
www.stemcellevidence.com/alerts/artic...

🆕 From the #StemCellEvidence alert:

📑 Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study by Li et al.

🔗Link in the comments
#MedSky

🔗 #StemCellEvidence link to:

Donor Related Logistical Challenges in Hematopoietic Transplant: A Comparative Analysis of Related and Unrelated Donors by LeMaistre et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🟣New from the #StemCellEvidence alert:

📑Donor Related Logistical Challenges in Hematopoietic Transplant: A Comparative Analysis of Related and Unrelated Donors by LeMaistre et al.

🔗Link in the comments

🟣 #StemCellEvidence link to:
Up to 19-year cryopreservation does not impair hematopoietic progenitor function in cord blood: a 1129-unit analysis from the largest Korean public cord blood bank
by Roh et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🆕 From the #StemCellEvidence alert:

📑Up to 19-year cryopreservation does not impair hematopoietic progenitor function in cord blood: a 1129-unit analysis from the largest Korean public cord blood bank
by Roh et al.
🔗 Link in the comments
#MedSky

🔗 #StemCellEvidence link to:
Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders by Pagliuca et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🟣New from the #StemCellEvidence alert:

➡️ Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders by Pagliuca et al.

🔗 Link in the comments
#MedSky

🔗 #StemCellEvidence link to:
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group
by Bazarbachi et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🆕From the #StemCellEvidence alert:

➡️Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group
by Bazarbachi et al.

🔗Link in the comments
#MedSky

🔗 #StemCellEvidence link to:
Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial
by Wu et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🟣 New from the #StemCellEvidence alert:

📑 Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial
by Wu et al.

🔗 Link in the comments
#MedSky

🔗 #StemCellEvidence link to:

Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial
by Jimenez Jimenez et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🆕 From the #StemCellEvidence alert:

📑 Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial
by Jimenez Jimenez et al.

🔗 Link in the comments
#MedSky

🔗 #StemCellEvidence link to:

GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches by Kirshenboim et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🟣 New from the #StemCellEvidence alert:

📑 GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches by Kirshenboim et al.

🔗 Link in the comments
#MedSky